Skip to main content

Table 1 Clinical, hormonal, and metabolic data in Met-anov and Met-ov groups, and in PCOS and non-PCOS controls.

From: Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin

Group

Met-anov

Met-ov

PCOS controls

Non-PCOS controls

 

Before treatment

Δ

Before treatment

Δ

  

Age (years)

27.40 ± 3.21

0.12 ± 0.15

28.08 ± 3.45

0.08 ± 0.29

27.83 ± 3.61

28.17 ± 3.58

BMI (kg/m 2 )

23.00 ± 1.58

-0.11 ± 0.25

22.97 ± 1.37

-0.06 ± 0.10

22.84 ± 1.64

23.09 ± 1.58

WHR

0.76 ± 0.12

0.01 ± 0.02

0.77 ± 0.10

-0.00 ± 0.06

0.76 ± 0.10

0.75 ± 0.98

Ferriman-Gallwey score

12.67 ± 2.70°

-1.84 ± 0.45

12.42 ± 2.43°

-0.09 ± 0.03

12.0 ± 2.98°

3.25 ± 1.91

FSH (mIU/mL)

5.85 ± 1.57

0.06 ± 0.03

5.86 ± 1.32

-0.03 ± 0.04

6.04 ± 1.39

5.50 ± 1.60

LH (mIU/mL)

11.89 ± 3.87°

-0.12 ± 0.31

12.56 ± 3.45°

-0.76 ± 0.25

12.56 ± 3.48°

10.43 ± 2.48

TSH (μU/mL)

2.94 ± 0.75

-0.02 ± 0.07

2.99 ± 0.72

-0.06 ± 0.05

2.81 ± 0.77

3.01 ± 0.65

PRL (ng/mL)

8.90 ± 2.13

0.08 ± 0.13

9.17 ± 1.83

1.26 ± 0.06

8.26 ± 2.13

9.20 ± 1.93

E 2 (pg/mL)

52.45 ± 16.43

0.53 ± 18.60

49.79 ± 14.98

0.26 ± 0.08

50.18 ± 11.00

52.24 ± 8.65

P (ng/mL)

1.38 ± 0.43

-0.02 ± 0.04

1.33 ± 0.44

-0.11 ± 0.09

1.40 ± 0.42

1.42 ± 0.36

17-OHP (μg/L)

2.25 ± 0.50

-0.28 ± 0.07

2.06 ± 0.46

-0.13 ± 0.07

2.20 ± 0.47

1.85 ± 0.41

T (ng/mL)

4.65 ± 1.15°

-1.14 ± 0.19

4.62 ± 1.13°

-0.35 ± 0.12

4.71 ± 1.02°

1.10 ± 0.29

A (ng/mL)

4.82 ± 1.91°

-1.63 ± 0.08

4.40 ± 1.13°

-0.20 ± 0.08

4.80 ± 1.14°

1.84 ± 0.45

DHEAS (ng/mL)

2674.10 ± 189.7°

-9.8 ± 0.25

2703.43 ± 204.42°

-17.55 ± 0.11

2696.66 ± 215.77°

1792.50 ± 253.84

SHBG (nmol/L)

32.41 ± 3.35 °†

0.49 ± 0.32

30.41 ± 1.88°

0.75 ± 1.06

30.50 ± 2.20°

49.45 ± 5.96

FAI (%)

14.50 ± 4.13°

-4.24 ± 1.39

14.63 ± 4.06°

-4.57 ± 0.07

14.78 ± 5.20°

3.73 ± 1.44

Fasting glucose (mmol/L)

4.60 ± 0.49

-0.35 ± 0.06

4.61 ± 0.47

-0.08 ± 0.08

4.52 ± 0.50

4.65 ± 0.46

Fasting insulin (μU/mL)

16.20 ± 4.82°†

-0.53 ± 0.22

16.51 ± 3.57°

-2.31 ± 0.11

16.30 ± 4.39°

14.36 ± 2.07

GIR (mg/10 -4 U)

5.64 ± 1.18°†

0.36 ± 0.10

5.40 ± 1.59°

1.17 ± 0.14

5.21 ± 1.41°

7.45 ± 1.24

HOMA

3.20 ± 0.61°†

-0.04 ± 0.17

3.73 ± 0.61°

-0.41 ± 0.11

3.17 ± 0.69°

2.90 ± 0.71

AMH (ng/mL)

5.23 ± 1.59°†

-2.0 ± 1.05

5.75 ± 1.59°

-7.41 ± 2.32

3.92 ± 1.62°

1.56 ± 1.02

  1. *p < 0.05 vs. before treatment assessment; †p < 0.05 vs. Met-ov group; ^p < 0.05 vs. PCOS controls; °p < 0.05 vs. non-PCOS controls.